Long-Acting Fluocinolone Acetonide Intravitreal Implant for Recurrent Bilateral Non-Infectious Posterior Uveitis
Adrian T Babel,1,2 Eric K Chin,3,4 David RP Almeida2 1Boonshoft School of Medicine, Dayton, OH, USA; 2Erie Retinal Surgery, Erie, PA, USA; 3Retina Consultants of Southern California, Redlands, CA, USA; 4Loma Linda Eye Institute, Veterans Affair Hospital, Loma Linda, CA, USACorrespondence: David RP A...
Main Authors: | Babel AT, Chin EK, Almeida DRP |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-11-01
|
Series: | International Medical Case Reports Journal |
Subjects: | |
Online Access: | https://www.dovepress.com/long-acting-fluocinolone-acetonide-intravitreal-implant-for-recurrent--peer-reviewed-fulltext-article-IMCRJ |
Similar Items
-
Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Non-Infectious Uveitis
by: Muaas Hikal, et al.
Published: (2021-09-01) -
Achieving Quiescence with Fluocinolone Implants
by: Freia McGregor, et al.
Published: (2021-05-01) -
Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis
by: Jong G. Park, et al.
Published: (2020-09-01) -
Intravitreal Fluocinolone Acetonide 0.19 mg Implant in a Patient with Resistant Blau Syndrome: A Case Report
by: Khushi Saigal, et al.
Published: (2024-01-01) -
Biomarkers to Predict the Success of Treatment with the Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Uveitic Macular Edema
by: Lucy Joanne Kessler, et al.
Published: (2022-03-01)